Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review

Overview of attention for article published in Multidisciplinary Respiratory Medicine, April 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 26,467 followers.

RT @iceman_ex: New in stable asthma: Omalizumab https://t.co/Ty9YhQhmoy Mepolizumab https://t.co/djztVsB0js Bronchial thermoplasty #ICS…

RT @iceman_ex: New in stable asthma: Omalizumab https://t.co/Ty9YhQhmoy Mepolizumab https://t.co/djztVsB0js Bronchial thermoplasty #ICS…

New in stable asthma: Omalizumab https://t.co/Ty9YhQhmoy Mepolizumab https://t.co/djztVsB0js Bronchial thermoplasty #ICSSOA2016

Treating severe allergic asthma with anti-IgE monoclonal antibody (omalizumab): a review. http://t.co/G5NPXUDbQP

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.